Protagonist Therapeutics, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shareholders voted to keep company leadership and approved new stock rewards for employees and executives.
Quarterly earnings show how the company performed in the first three months of the year.
Quarterly earnings show how the company performed in the first three months of the year.
Annual earnings show total company performance and financial health for the entire year.
Annual earnings show total company performance and financial health for the entire year.
Stocky reads Protagonist Therapeutics, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Protagonist Therapeutics, Inc.'s most recent tracked filing was a 8-K on 18 Jun 2026: Stockholders elect directors and approve 2026 equity plan.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.